Literature DB >> 23988397

Bias in breast cancer research in the screening era.

Brian Cox1, Mary J Sneyd.   

Abstract

Screening aims to detect breast cancer at an earlier stage than would occur if symptoms developed. The characteristics of breast cancer that are detectable at screening depend on both the physical properties of the screening test and specific anatomical features of breast cancer. As a result, breast cancer detected by screening is a select subset of all breast cancer existing in the population. Therefore, biomedical, clinical and epidemiological research into breast cancer using populations with access to screening can result in major bias. The biases, with examples, are explained.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bias; Lead time; Length bias; Overdiagnosis; Screening; Selection

Mesh:

Year:  2013        PMID: 23988397     DOI: 10.1016/j.breast.2013.07.046

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  8 in total

1.  Mammography, Martin Yaffe, and me: response and appreciation.

Authors:  Constantine Kaniklidis
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

2.  Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study.

Authors:  Steven Habbous; Esha Homenauth; Andriana Barisic; Sharmilaa Kandasamy; Vicky Majpruz; Katharina Forster; Marta Yurcan; Anna M Chiarelli; Patti Groome; Claire M B Holloway; Andrea Eisen
Journal:  CMAJ Open       Date:  2022-04-05

3.  Mammography screening is associated with more favourable breast cancer tumour characteristics and better overall survival: case-only analysis of 3739 Asian breast cancer patients.

Authors:  Jingmei Li; Mikael Hartman; Zi Lin Lim; Peh Joo Ho; Alexis Jiaying Khng; Yen Shing Yeoh; Amanda Tse Woon Ong; Benita Kiat Tee Tan; Ern Yu Tan; Su-Ming Tan; Geok Hoon Lim; Jung Ah Lee; Veronique Kiak-Mien Tan; Jesse Hu
Journal:  BMC Med       Date:  2022-08-04       Impact factor: 11.150

4.  Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study.

Authors:  Nienke A de Glas; Anton J M de Craen; Esther Bastiaannet; Ester G Op 't Land; Mandy Kiderlen; Willemien van de Water; Sabine Siesling; Johanneke E A Portielje; Herman M Schuttevaer; Geertruida Truuske H de Bock; Cornelis J H van de Velde; Gerrit-Jan Liefers
Journal:  BMJ       Date:  2014-09-14

5.  Recent Improvement in the Long-term Survival of Breast Cancer Patients by Age and Stage in Japan.

Authors:  Akiyo Yoshimura; Hidemi Ito; Yoshikazu Nishino; Masakazu Hattori; Tomohiro Matsuda; Isao Miyashiro; Tomio Nakayama; Hiroji Iwata; Keitaro Matsuo; Hideo Tanaka; Yuri Ito
Journal:  J Epidemiol       Date:  2018-02-24       Impact factor: 3.211

6.  Risk factors for Luminal A ductal carcinoma in situ (DCIS) and invasive breast cancer in the Carolina Breast Cancer Study.

Authors:  Lindsay A Williams; Patricia Casbas-Hernandez; Hazel B Nichols; Chiu Kit Tse; Emma H Allott; Lisa A Carey; Andrew F Olshan; Melissa A Troester
Journal:  PLoS One       Date:  2019-01-25       Impact factor: 3.240

7.  Risk factors for estrogen receptor positive ductal carcinoma in situ of the breast in African American women.

Authors:  Kimberly A Bertrand; Traci N Bethea; Lynn Rosenberg; Elisa V Bandera; Thaer Khoury; Melissa A Troester; Christine B Ambrosone; Julie R Palmer
Journal:  Breast       Date:  2019-11-06       Impact factor: 4.380

8.  Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.

Authors:  Cecilie Kyrø; Raul Zamora-Ros; Augustin Scalbert; Anne Tjønneland; Laure Dossus; Christoffer Johansen; Pernille Envold Bidstrup; Elisabete Weiderpass; Jane Christensen; Heather Ward; Dagfinn Aune; Elio Riboli; Mathilde His; Françoise Clavel-Chapelon; Laura Baglietto; Verena Katzke; Tilman Kühn; Heiner Boeing; Anna Floegel; Kim Overvad; Cristina Lasheras; Noémie Travier; Maria-José Sánchez; Pilar Amiano; Maria-Dolores Chirlaque; Eva Ardanaz; Kay-Tee Khaw; Nick Wareham; Aurora Perez-Cornago; Antonia Trichopoulou; Pagona Lagiou; Effie Vasilopoulou; Giovanna Masala; Sara Grioni; Franco Berrino; Rosario Tumino; Carlotta Sacerdote; Amalia Mattiello; H Bas Bueno-de-Mesquita; Petra H Peeters; Carla van Gils; Signe Borgquist; Salma Butt; Anne Zeleniuch-Jacquotte; Malin Sund; Anette Hjartåker; Guri Skeie; Anja Olsen; Isabelle Romieu
Journal:  Breast Cancer Res Treat       Date:  2015-11-03       Impact factor: 4.872

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.